Treatment of Low Ionized Calcium
For symptomatic acute hypocalcemia, immediately administer IV calcium gluconate as a bolus (90-180 mg elemental calcium over 10-20 minutes) followed by continuous infusion, with concurrent initiation of oral calcium and calcitriol. 1
Acute Hypocalcemia Management
When to Treat Urgently
IV calcium therapy is indicated when:
- Severe symptoms present: seizures, laryngospasm, bronchospasm, or severe tetany
- Albumin-corrected serum calcium <7.5 mg/dL (1.9 mmol/L) 1
- QTc prolongation (>0.45 s in men, >0.47 s in women) 1
- Patient unable to take oral supplements or has seizure history
IV Calcium Administration Protocol
Initial Bolus:
- Give 1 gram IV calcium gluconate (90 mg elemental calcium) over 10-20 minutes 1
- Use calcium gluconate preferentially over calcium chloride due to lower risk of tissue necrosis if extravasation occurs 1
- Administer via large bore needle with secure IV access
- Cardiac monitoring is mandatory - rapid infusion can cause cardiac arrest 1
Continuous Infusion:
- Mix 10 ampules calcium gluconate (900 mg elemental calcium) in 1 liter of 5% dextrose or normal saline 1
- Start at 100 mL/hour and titrate based on ionized calcium levels 1
- Do not add bicarbonate or phosphate - they form insoluble calcium salts 1
- Expected effect: 15 mg/kg elemental calcium over 4-6 hours raises serum calcium by approximately 0.5-0.75 mmol/L 1
Monitoring During Acute Treatment:
- Check ionized calcium (preferred) or albumin-corrected calcium every 6 hours initially, then daily until stable 1
- Target: restore calcium to just below normal reference range 1
Concurrent Oral Therapy
Start immediately alongside IV calcium:
Critical Pitfall: Correct Hypomagnesemia First
Always check and correct magnesium levels - hypocalcemia cannot be effectively treated in the presence of hypomagnesemia 1
Chronic Hypocalcemia Management
Treatment Goals
The six key objectives are 2:
- Prevent symptoms of hypocalcemia
- Maintain serum calcium slightly below normal or low-normal range (no more than 0.5 mg/dL below normal)
- Maintain calcium-phosphate balance with product <55 mg²/dL² (4.4 mmol²/L²)
- Avoid hypercalciuria (target <250 mg/24h for women, <300 mg/24h for men) 1
- Avoid hypercalcemia
- Prevent nephrocalcinosis/nephrolithiasis and extraskeletal calcifications
Conventional Therapy Components
Calcium supplementation:
- Take with meals for better absorption 1
- Adjust doses based on clinical stability
Active vitamin D:
- Calcitriol or alfacalcidol as primary therapy 2
- Parent vitamin D (cholecalciferol/ergocalciferol) may be useful adjunct 2
Thiazide diuretics:
Phosphate management:
- Phosphate binders and low-phosphate diet if hyperphosphatemia develops 2
Monitoring Schedule
Stable patients 1:
- Serum calcium, albumin, phosphorus, magnesium, eGFR: every 3-12 months
- 25(OH)D: every 6-12 months once in target range
- 24-hour urine calcium and creatinine: every 6-24 months
Unstable patients:
- Recheck serum calcium within several days after any significant medication changes 1
- If doses changed, repeat albumin-corrected calcium in 4-7 days 1
Important Caveats
Measurement considerations:
- Ionized calcium is the gold standard - total calcium measurements are inaccurate in severe depletion even when "corrected" for albumin 3, 4
- Timing matters: blood draw timing relative to calcium supplement or active vitamin D administration affects results 1
- Single measurements may not reflect calcium fluctuations 1
Biotin interference:
- Stop biotin (if >5 mg daily) for at least 3 days before PTH testing - it can falsely lower PTH in some assays 1
Limitations of conventional therapy 1:
- Does not prevent calcium fluctuations
- High pill burden
- Requires dose adjustments during exercise, menses, increased calcium requirements
- Active vitamin D increases both serum phosphorus and urine calcium
- May not fully relieve symptoms or improve quality of life
The most recent 2025 guidelines 1 emphasize that while conventional therapy effectively raises serum calcium, maintaining stable levels can be challenging and requires careful, individualized monitoring based on clinical stability.